ADC Therapeutics SA (NYSE:ADCT) Q1 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to ADC Therapeutics' First Quarter 2025 Earnings Call.
Adc Therapeutics Sa (ADCT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 15,666,731 | $22,090,091 | 2.09% | |
| 2. | Prosight Capital Lawrence Hawkins | 9,543,004 | $13,455,636 | +1% | 4.42% |
| 3. | OrbiMed Advisors Samuel Isaly | 5,968,451 | $8,415,516 | 0.2% | |
| 4. | Platinum Asset Management Kerr Neilson | 2,038,087 | $2,873,703 | +27% | 0.17% |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 815,531 | $1,149,899 | -58% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.81 | 50,000 | $190,500.00 | 13,145,712 | 2024-12-11 | Filing | |
| $2.28 | 50,000 | $114,000.00 | 13,095,712 | 2024-12-11 | Filing | |
| $3.81 | 50,000 | $190,500.00 | 15,666,731 | 2024-12-11 | Filing | |
| $2.28 | 50,000 | $114,000.00 | 15,616,731 | 2024-12-11 | Filing | |
| $2.81 | 400,000 | $1,124,000.00 | 12,995,040 | 2024-07-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.07 | 25,352 | $52,478.64 | 15,566,731 | 2024-12-04 | Filing | |
| $2.89 | 6,995 | $20,215.55 | 53,005 | 2024-06-17 | Filing | |
| $2.89 | 6,995 | $20,215.55 | 79,502 | 2024-06-17 | Filing | |
| $2.89 | 1,193 | $3,447.77 | 182,644 | 2024-06-17 | Filing | |
| $2.89 | 1,437 | $4,152.93 | 106,627 | 2024-06-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,913,628 | $6,928,215 | 0% | |
| 2. | 3,019,585 | $4,257,615 | 0% | |
| 3. | 1,801,154 | $2,539,627 | 0% | |
| 4. | 1,583,112 | $2,232,188 | 0% | |
| 5. | 1,211,346 | $1,707,998 | 0% |
News See All
ADC Therapeutics SA (NYSE:ADCT) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics Fourth Quarter Fiscal Year 2024 Earnings Conference Call. At this time, all lines are in listen-only mode.
ADC Therapeutics SA (NYSE:ADCT) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics Third Quarter 2024 Earnings Conference Call.
ADC Therapeutics SA (NYSE:ADCT) Q2 2024 Earnings Call Transcript
Operator: Welcome to the ADC Therapeutics Second Quarter 2024 Financial Results Conference Call. My name is Didi, and I will be your operator for today's call.
ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript
ADC Therapeutics SA reports earnings inline with expectations. Reported EPS is $-0.56 EPS, expectations were $-0.56.
ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript
ADC Therapeutics SA misses on earnings expectations. Reported EPS is $-1.03 EPS, expectations were $-0.47.
5 Top Performing European Stocks So Far in 2024
In this piece, we will take a look at the five top performing European stocks so far in 2024.
ADC Therapeutics SA (NYSE:ADCT) Q3 2023 Earnings Call Transcript
Operator: Welcome to the ADC Therapeutics Third Quarter 2023 Financial Results Conference Call. My name is Cathy and I will be your operator for today's call.
ADC Therapeutics SA (NYSE:ADCT) Q2 2023 Earnings Call Transcript
Operator: Hello, and welcome to the ADC Therapeutics Second Quarter 2023 Financial Results Conference Call. My name is Corey, and I'll be your operator for today's call.
ADC Therapeutics SA (NYSE:ADCT) Q4 2022 Earnings Call Transcript
Operator: Welcome to the ADC Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. My name is Andrew, and I'll be your operator for today's call.
Billionaire Hedge Funds
